Company Filing History:
2 out of 15,502 
2 out of 7 
1 out of 13 
Years Active: 1999-2021
Title: The Innovative Contributions of Mohammed Kashani-Sabet
Introduction
Mohammed Kashani-Sabet is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of cancer research, holding a total of five patents. His work focuses on developing methods for predicting cancer progression and creating targeted therapies.
Latest Patents
Kashani-Sabet's latest patents include MIR-18B, which serves as a marker for cancer progression and a target for therapies. This patent outlines methods for predicting whether a subject has cancer based on the expression levels of miR-18b. It also details how to determine if a cancer is progressing or regressing by comparing expression levels at two different time points. Additionally, it provides treatment methods involving the administration of polynucleotides that enhance miR-18b expression. Another significant patent is FALZ, which targets therapies for cancer treatment. This patent describes methods for predicting cancer based on BPTF expression levels and determining cancer progression through changes in these levels. It also includes treatment methods using inhibitory BPTF nucleic acids.
Career Highlights
Throughout his career, Kashani-Sabet has worked with esteemed institutions such as the University of California and Sutter Bay Hospitals. His research has been pivotal in advancing cancer treatment methodologies.
Collaborations
Kashani-Sabet has collaborated with notable professionals in his field, including Altaf A Dar and Christopher Haqq. Their combined expertise has contributed to the development of innovative cancer therapies.
Conclusion
Mohammed Kashani-Sabet's work exemplifies the impact of innovation in cancer research. His patents and collaborations highlight his commitment to improving cancer treatment and patient outcomes.